BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SHR-3821 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of SHR-3821\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07515820-11117@assetmemo.bio
DTSTAMP:20261121T005619Z
DTSTART;VALUE=DATE:20270728
DTEND;VALUE=DATE:20270729
SUMMARY:SHR-3821: Phase 2 readout est. (NCT07515820)
DESCRIPTION:SHR-3821\, phase 2.\nStudy: SHR-3821 in Advanced Colorectal Can
 cer: an Exploratory Study\nEstimated primary completion: 28 July 2027. Thi
 s is a ClinicalTrials.gov estimate\, not a confirmed readout date\, and it
  can move.\nDrug page: https://assetmemo.bio/drug/shr-3821#upcoming-events
 \nRegistry record: https://clinicaltrials.gov/study/NCT07515820
URL:https://assetmemo.bio/drug/shr-3821#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
